Alexandra Cochran
The Clinical Impact of GLP-1 and GIP/GLP-1 Receptor Agonist Access Issues in a Primary Care Setting
Alexandra Cochran is a PGY-1 community based pharmacy resident at South College School of Pharmacy.
“I am honored to receive an Incentive Grant this year to further discuss the clinical impact of access issues on patients receiving GLP-1 and GIP/GLP-1 receptor agonist therapy. This grant will allow me to explore the barriers that prevent patients from accessing these essential medications, which are critical in the management of type II diabetes mellitus. By understanding how these obstacles affect clinical outcomes such as HbA1c levels and weight management, I hope to contribute valuable insights that can inform healthcare policies and improve patient care in primary care settings.
My motivation for pursuing this research stems from a desire to improve the quality of care for patients with type II diabetes, particularly those facing barriers to accessing vital therapies like GLP-1 and GIP/GLP-1 receptor agonists. I have seen firsthand how access issues can negatively impact patient outcomes, and I am driven to identify solutions that can make these treatments more accessible for my patients. Ultimately, my goal is to contribute to the development of strategies that will enhance patient care and lead to better long-term health outcomes for the patients that I see on a regular basis in clinic.
What excites me most about this project is the opportunity to directly impact patient care by addressing access issues that can significantly affect health outcomes. I'm eager to explore how overcoming these barriers can lead to better management of type II diabetes, improving both HbA1c levels and overall patient well-being. I am excited to make meaningful differences in my patient’s health care journey.”